SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-19-021135
Filing Date
2019-04-12
Accepted
2019-04-12 16:34:37
Documents
5
Effectiveness Date
2019-04-12

Document Format Files

Seq Description Document Type Size
1 DEFA14A a19-7613_3defa14a.htm DEFA14A 32116
2 GRAPHIC g76133bei001.jpg GRAPHIC 114865
3 GRAPHIC g76133bei002.jpg GRAPHIC 185524
4 GRAPHIC g76133bei003.jpg GRAPHIC 53590
5 GRAPHIC g76133bei004.jpg GRAPHIC 30506
  Complete submission text file 0001104659-19-021135.txt   562902
Mailing Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139 617-679-9600
Rubius Therapeutics, Inc. (Filer) CIK: 0001709401 (see all company filings)

IRS No.: 042688109 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38586 | Film No.: 19746662
SIC: 2836 Biological Products, (No Diagnostic Substances)